T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.06% |
| 2 | Financials | 16.98% |
| 3 | Consumer Discretionary | 15.13% |
| 4 | Technology | 13.74% |
| 5 | Industrials | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Nasdaq
NDAQ
$54.2B
| $14.5M | ﹤0.01% |
650,070
+15,156
| +2% | +$334K |
|
1227
Weyco Group
WEYS
$430M
| $14.5M | ﹤0.01% |
462,453
-38,582
| -8% | -$1.08M |
|
1228
Generac Holdings
GNRC
$13B
| $14.4M | ﹤0.01% |
354,455
+30,000
| +9% | +$1.19M |
|
|
CDEVW
1229
DELISTED
Centennial Resource Development, Inc. Warrants Business Combination
CDEVW
| $14.4M | ﹤0.01% |
+1,728,262
| New | +$10.4M |
|
|
NTUS
1230
DELISTED
Natus Medical Inc
NTUS
| $14.4M | ﹤0.01% |
412,930
-450
| -0.1% | -$17.7K |
|
|
OA
1231
DELISTED
Orbital ATK, Inc.
OA
| $14.3M | ﹤0.01% |
162,886
+48
| +0% | +$3.91K |
|
|
HAWK
1232
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $14.3M | ﹤0.01% |
378,612
-38,090
| -9% | -$1.36M |
|
1233
ACI Worldwide
ACIW
$5.36B
| $14.1M | ﹤0.01% |
779,398
-27,830
| -3% | -$521K |
|
|
CAA
1234
DELISTED
CalAtlantic Group, Inc.
CAA
| $14.1M | ﹤0.01% |
415,590
+680
| +0.2% | +$22.5K |
|
|
BID
1235
DELISTED
Sotheby's
BID
| $14M | ﹤0.01% |
351,574
-722
| -0.2% | -$27.4K |
|
1236
Capri Holdings
CPRI
$1.76B
| $14M | ﹤0.01% |
325,225
-580
| -0.2% | -$27.5K |
|
1237
NVR
NVR
$16.8B
| $13.9M | ﹤0.01% |
8,356
+420
| +5% | +$671K |
|
1238
Stratasys
SSYS
$782M
| $13.9M | ﹤0.01% |
841,712
-13,200
| -2% | -$259K |
|
1239
Diageo
DEO
$53.1B
| $13.7M | ﹤0.01% |
131,959
+1,900
| +1% | +$200K |
|
1240
Fluor
FLR
$7.04B
| $13.7M | ﹤0.01% |
260,514
-1,300
| -0.5% | -$67.5K |
|
|
PRAH
1241
DELISTED
PRA Health Sciences, Inc.
PRAH
| $13.6M | ﹤0.01% |
245,928
+12,160
| +5% | +$667K |
|
|
AXE
1242
DELISTED
Anixter International Inc
AXE
| $13.6M | ﹤0.01% |
167,180
-10,900
| -6% | -$789K |
|
|
AIV
1243
Aimco
AIV
$385M
| $13.5M | ﹤0.01% |
2,230,099
+21,019
| +1% | +$120K |
|
|
BLCM
1244
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $13.4M | ﹤0.01% |
98,454
-18,832
| -16% | -$3.34M |
|
|
TMUSP
1245
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $13.3M | ﹤0.01% |
141,289
| – | – |
|
1246
REX American Resources
REX
$1.47B
| $13.2M | ﹤0.01% |
804,696
-77,724
| -9% | -$1.15M |
|
1247
Accuray
ARAY
$33.8M
| $13.2M | ﹤0.01% |
2,873,247
-11,340
| -0.4% | -$58.8K |
|
1248
Sportsman's Warehouse
SPWH
$46M
| $13.2M | ﹤0.01% |
1,402,971
-94,360
| -6% | -$895K |
|
1249
Constellium
CSTM
$4.03B
| $13.2M | ﹤0.01% |
2,231,420
+1,000
| +0% | +$6.11K |
|
1250
Integer Holdings
ITGR
$4.26B
| $13.1M | ﹤0.01% |
445,160
+4,210
| +1% | +$106K |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.